Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Biovectors Influenza Vaccine Shows Positive Phase I Results

Nov. 4, 1998

Flamel Reports Revenue Rise; Plans Launch Of First Product

Nov. 4, 1998

Glaxo Asking For FDA Approval To Market Biotas Flu Drug

Nov. 4, 1998

GlycoDesign Aims To Uncloak Bacterias Defense Mechanisms

Nov. 4, 1998

Peptide Therapeutics Starts Phase I Of Diarrhea Drug

Nov. 4, 1998

TAB Faces Major-Discount Financing, Potential Insolvency

Nov. 4, 1998

Applighne Posts Increase In Sales

Oct. 28, 1998

Alzheimers Disease Research In Mice Showing More Promise

Oct. 28, 1998

Gensets Goal Of Profitability In 1999 Boosted By 3Q Results

Oct. 28, 1998

European Confusion Continues To Grow On Rules For Biotech

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...